IBD therapeutic endpoints have evolved over time with the addition of mucosal healing (MH) as a treatment goal. Adult data suggest patients who achieve MH have improved outcomes but pediatric data is lacking. The aims of our study was to evaluate the rate of MH, to correlate MH with clinical remission and identify medications associated with MH.